Botulinum Toxin Type A for Treating Depression
Author Information
Author(s): RodrÃguez-Cerdeira Carmen, Eckhardt Westley
Primary Institution: University of Vigo
Hypothesis
Does botulinum toxin type A injected into the muscles of the upper third of the face have antidepressant effects in patients diagnosed with depression?
Conclusion
Botulinum toxin type A has been shown to have an antidepressant effect by preventing contractions of facial muscles associated with sadness.
Supporting Evidence
- Botulinum toxin type A injections have shown strong evidence of effectiveness for treatment-resistant depression.
- Facial feedback theory supports the idea that facial expressions can influence emotional states.
- Studies indicate that BoNT injections in the glabellar region exhibit anti-depressant effects.
Takeaway
Injecting a special medicine called botulinum toxin into the face can help people feel less sad by stopping their frowning muscles from working.
Methodology
The study reviewed 155 articles and selected 55 original articles for analysis based on specific inclusion and exclusion criteria.
Potential Biases
Potential bias due to the subjective nature of self-reported depression scores.
Limitations
The review was limited to articles that offered detailed descriptions of the treatment approaches and did not include all studies on the topic.
Participant Demographics
Most participants were women, with some studies including men with bipolar depression.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website